Vanessa Milogiannakis
UNSW Sydney(AU)Baird Institute(AU)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Immunodeficiency and Autoimmune Disorders, SARS-CoV-2 detection and testing, Long-Term Effects of COVID-19
Most-Cited Works
- → SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern(2022)156 cited
- → SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern(2021)72 cited
- → Emergence and antibody evasion of BQ, BA.2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level(2023)54 cited
- → Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia(2022)54 cited
- → COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity(2021)45 cited
- → Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion(2022)40 cited
- → Improvement of immune dysregulation in individuals with long COVID at 24-months following SARS-CoV-2 infection(2024)37 cited
- → Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2(2023)24 cited
- → High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells(2022)19 cited
- → Macrophages direct location-dependent recall of B cell memory to vaccination(2025)17 cited